Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional)- RFA-AI-24-018 |
R01
|
March 28, 2024 |
July 31, 2024 |
Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional)- RFA-AI-24-009 |
UG3/UH3
|
March 28, 2024 |
July 31, 2024 |
Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (U01 Clinical Trial Not Allowed)- RFA-AI-24-016 |
U01
|
March 27, 2024 |
June 22, 2024 |
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)- RFA-AI-24-006 |
U01
|
March 27, 2024 |
June 22, 2024 |
Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV)- NOT-AI-24-028 |
Multiple |
March 27, 2024 |
April 06, 2027 |
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowed)- RFA-AI-24-008 |
R01
|
March 27, 2024 |
July 31, 2024 |
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)- RFA-AI-24-010 |
R01
|
March 27, 2024 |
June 29, 2024 |
Notice of Special Interest: Womens Health Research- NOT-OD-24-079 |
Multiple |
March 26, 2024 |
November 05, 2027 |
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)- RFA-AI-24-011 |
UM1
|
March 21, 2024 |
July 31, 2024 |
Notice of Special Interest (NOSI): Inborn Errors of Immunity/Primary Immunodeficiencies- NOT-AI-24-024 |
R03, R01, R21
|
March 20, 2024 |
March 17, 2027 |
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)- PAR-24-144 |
R16
|
March 14, 2024 |
January 08, 2027 |
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)- PAR-24-145 |
R16
|
March 14, 2024 |
January 08, 2027 |
Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)- RFA-AI-23-077 |
U54
|
March 13, 2024 |
July 31, 2024 |
Notice of Special Interest (NOSI): Chemical Countermeasures Research Program (CCRP) Administrative Supplements to Promote the Development of Pediatric Research Models of Chemical Injury and Medical Countermeasures Discovery- NOT-AI-24-022 |
Supp
|
March 08, 2024 |
March 17, 2026 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)- PA-24-141 |
R13
|
March 06, 2024 |
January 08, 2027 |
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)- PA-23-317 |
Multiple |
February 29, 2024 |
November 24, 2026 |
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)- RFA-DK-25-013 |
R01
|
February 29, 2024 |
July 31, 2024 |
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)- RFA-OD-24-013 |
K12
|
February 26, 2024 |
May 29, 2026 |
Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health- NOT-ES-24-002 |
R43/R44, R41/R42
|
February 15, 2024 |
April 06, 2025 |
Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)- NOT-AI-24-007 |
R43/R44, R41/R42
|
February 02, 2024 |
January 06, 2027 |
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-24-099 |
U44
|
January 29, 2024 |
January 14, 2027 |
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)- PAR-24-100 |
U01
|
January 29, 2024 |
January 14, 2027 |
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)- RFA-AI-24-003 |
U01
|
January 25, 2024 |
June 01, 2024 |
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)- PAR-24-111 |
R21
|
January 25, 2024 |
January 08, 2027 |
Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)- PAR-24-112 |
R01
|
January 25, 2024 |
January 08, 2027 |